@article{021c2ee0f6a24f6d9853aff2c0369b47,
title = "The value of cholera vaccines reassessed",
author = "Glass, {Roger I.} and Steele, {A. Duncan}",
note = "Funding Information: No country currently uses a cholera vaccine in routine public-health practice, but efforts to control outbreaks by using vaccines have met with some recent successes. In Micronesia, use of a live cholera vaccine was credited with controlling the spread of a larger epidemic. 7 In Beira, Mozambique, the killed cholera vaccine controlled a large seasonal epidemic, leading the Ministry of Health to want to try more widespread introduction. 8 Ali and co-workers' study is part of an ongoing series of projects at the International Vaccine Institute in Seoul, Korea, which is supported through a grant from the Bill & Melinda Gates Foundation, to define conditions where cholera vaccines would represent an important public-health tool. Because cholera is a geographically limited disease, part of the challenge is to define the cholera belts and the conditions where a vaccine could save lives. But this is not an easy task since many countries with cholera do not report cases to WHO because of possible economic repercussions: such losses resulting from an inability to sell seafood and from a decline in the number of travellers willing to visit the country. In addition, in the past decade, the number of displaced populations and refugee communities in Africa has swollen, making it difficult to define those groups at greatest risk. ",
year = "2005",
month = jul,
day = "2",
doi = "10.1016/S0140-6736(05)66551-8",
language = "English",
volume = "366",
pages = "7--9",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier B.V.",
number = "9479",
}
